CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Plerixafor

普乐沙福 杂质对照品Plerixafor Impurities

47 个杂质条目47 impurity entries

本页汇总 普乐沙福 的 47 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 47 impurity reference standards of Plerixafor. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 普乐沙福(Plerixafor)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesRobust and Rugged Stability-Indicating HPLC Method for the Determination of Plerixafor and Its Related Impurities in Drug Substances
    Journal of chromatographic science · 2015 · Bapatu HR et al.  ·  PMID 25858970  ·  DOI
  2. 杂质研究Impurity studiesCXCR4 antagonist AMD3100 (plerixafor): From an impurity to a therapeutic agent
    Pharmacological research · 2020 · Wang J et al.  ·  PMID 32544428  ·  DOI
  3. 分析方法Analytical MethodsCorrection: Screening of cancer tissue arrays identifies CXCR4 on adrenocortical carcinoma: correlates with expression and quantification on metastases using (64)Cu-plerixafor PET
    Oncotarget · 2018 · Weiss ID et al.  ·  PMID 30349656  ·  DOI
  4. 分析方法Analytical MethodsChemical Stability of Plerixafor after Opening of Single-Use Vial
    The Canadian journal of hospital pharmacy · 2017 · Seki JT et al.  ·  PMID 28894310  ·  DOI
  5. 分析方法Analytical MethodsScreening of cancer tissue arrays identifies CXCR4 on adrenocortical carcinoma: correlates with expression and quantification on metastases using (64)Cu-plerixafor PET
    Oncotarget · 2017 · Weiss ID et al.  ·  PMID 29088715  ·  DOI

普乐沙福 —— 原料药与杂质对照品Plerixafor — drug substance & impurities

共 47 个条目(含原料药本体)47 items incl. the drug substance
Plerixafor Monomer-d4 structure
—
普乐沙福 单体-d4Plerixafor Monomer-d4
Plerixafor Monomer-d4
CAS No.1246819-87-3
Chemical FormulaC28H50D4N8
Purity>95%询价On request
Plerixafor Octahydrochloride structure
—
普乐沙福八盐酸盐Plerixafor Octahydrochloride
Plerixafor Octahydrochloride
CAS No.155148-31-5
Chemical FormulaC28H54N8·8HCl
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 1 structure
1
普乐沙福杂质1Plerixafor Impurity 1
Plerixafor Impurity 1
CAS No.548488-49-9
Chemical FormulaC12H23F3N4O
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 3 structure
3
普乐沙福杂质3Plerixafor Impurity 3
Plerixafor Impurity 3
CAS No.201610-16-4
Chemical FormulaC18H20F12N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 4 structure
4
普乐沙福杂质4Plerixafor Impurity 4
Plerixafor Impurity 4
CAS No.104395-69-9
Chemical FormulaC31H42N4O6S3
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 5 structure
5
普乐沙福杂质5Plerixafor Impurity 5
Plerixafor Impurity 5
CAS No.123530-19-8
Chemical FormulaC24H36N4O4S2
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 6 structure
6
普乐沙福杂质6Plerixafor Impurity 6
Plerixafor Impurity 6
CAS No.117152-73-5
Chemical FormulaC24H36N4O4S2
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 7 structure
7
普乐沙福杂质7Plerixafor Impurity 7
Plerixafor Impurity 7
CAS No.117152-72-4
Chemical FormulaC24H36N4O4S2
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 8 structure
8
普乐沙福杂质8Plerixafor Impurity 8
Plerixafor Impurity 8
CAS No.128495-29-4
Chemical FormulaC17H30N4O2S
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 8 Trihydrochloride structure
8
普乐沙福杂质8三盐酸盐Plerixafor Impurity 8 Trihydrochloride
Plerixafor Impurity 8 Trihydrochloride
CAS No.128495-30-7
Chemical FormulaC17H30N4O2S·3HCl
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 9 structure
9
普乐沙福杂质9Plerixafor Impurity 9
Plerixafor Impurity 9
CAS No.181181-38-4
Chemical FormulaC22H34N4O4S2
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 12 structure
12
普乐沙福杂质12Plerixafor Impurity 12
Plerixafor Impurity 12
CAS No.13380-07-9
Chemical FormulaC22H34N4O4S2
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 14 structure
14
普乐沙福杂质14Plerixafor Impurity 14
Plerixafor Impurity 14
CAS No.294677-00-2
Chemical FormulaC22H34N4O4S2
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 17 structure
17
普乐沙福杂质17Plerixafor Impurity 17
Plerixafor Impurity 17
CAS No.548488-50-2
Chemical FormulaC14H22F6N4O2
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 19 structure
19
普乐沙福杂质19Plerixafor Impurity 19
Plerixafor Impurity 19
CAS No.1254176-45-8
Chemical FormulaC18H30N4O
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 21 structure
21
普乐沙福杂质21Plerixafor Impurity 21
Plerixafor Impurity 21
CAS No.2173049-85-7
Chemical FormulaC46H84N12·12HCl
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 25 structure
25
普乐沙福杂质25Plerixafor Impurity 25
Plerixafor Impurity 25
CAS No.176252-20-3
Chemical FormulaC18H32N4O
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 26 structure
26
普乐沙福杂质26Plerixafor Impurity 26
Plerixafor Impurity 26
CAS No.406939-92-2
Chemical FormulaC16H21F9N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 27 structure
27
普乐沙福杂质27Plerixafor Impurity 27
Plerixafor Impurity 27
CAS No.406939-93-3
Chemical FormulaC40H48F18N8O6
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 34 structure
34
普乐沙福杂质34Plerixafor Impurity 34
Plerixafor Impurity 34
CAS No.170161-28-1
Chemical FormulaC20H40N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 35 structure
35
普乐沙福杂质35Plerixafor Impurity 35
Plerixafor Impurity 35
CAS No.214078-93-0
Chemical FormulaC24H36N4
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 36 structure
36
普乐沙福杂质36Plerixafor Impurity 36
Plerixafor Impurity 36
CAS No.1007858-12-9
Chemical FormulaC30H56N4O8
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 37 structure
37
普乐沙福杂质37Plerixafor Impurity 37
Plerixafor Impurity 37
CAS No.170161-27-0
Chemical FormulaC25H48N4O6
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 38 structure
38
普乐沙福杂质38Plerixafor Impurity 38
Plerixafor Impurity 38
CAS No.170161-29-2
Chemical FormulaC20H40N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 41 structure
41
普乐沙福杂质41Plerixafor Impurity 41
Plerixafor Impurity 41
CAS No.477808-34-1
Chemical FormulaC37H48N4O8S4
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 42 structure
42
普乐沙福杂质42Plerixafor Impurity 42
Plerixafor Impurity 42
CAS No.71089-74-2
Chemical FormulaC38H48N4O8S4
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 43 structure
43
普乐沙福杂质43Plerixafor Impurity 43
Plerixafor Impurity 43
CAS No.80413-59-8
Chemical FormulaC8H7Br3
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 44 structure
44
普乐沙福杂质44Plerixafor Impurity 44
Plerixafor Impurity 44
CAS No.16473-35-1
Chemical FormulaC8H9ClO
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 47 structure
47
普乐沙福杂质47Plerixafor Impurity 47
Plerixafor Impurity 47
CAS No.6315-52-2
Chemical FormulaC16H18O6S2
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 49 structure
49
普乐沙福杂质49Plerixafor Impurity 49
Plerixafor Impurity 49
CAS No.104-82-5
Chemical FormulaC8H9Cl
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 50 structure
50
普乐沙福杂质50Plerixafor Impurity 50
Plerixafor Impurity 50
CAS No.626-16-4
Chemical FormulaC8H8Cl2
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 51 structure
51
普乐沙福杂质51Plerixafor Impurity 51
Plerixafor Impurity 51
CAS No.612-12-4
Chemical FormulaC8H8Cl2
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 52 structure
52
普乐沙福杂质52Plerixafor Impurity 52
Plerixafor Impurity 52
CAS No.73291-09-5
Chemical FormulaC8H7ClO
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 54 structure
54
普乐沙福杂质54Plerixafor Impurity 54
Plerixafor Impurity 54
CAS No.351472-73-6
Chemical FormulaC18H32N4
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 55 structure
55
普乐沙福杂质55Plerixafor Impurity 55
Plerixafor Impurity 55
CAS No.2841376-04-1
Chemical FormulaC25H50N8
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 56 structure
56
普乐沙福杂质56Plerixafor Impurity 56
Plerixafor Impurity 56
CAS No.732221-38-4
Chemical FormulaC26H52N8
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 58 structure
58
普乐沙福杂质58Plerixafor Impurity 58
Plerixafor Impurity 58
CAS No.1165800-04-3
Chemical FormulaC25H50N8
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 62 structure
62
普乐沙福杂质62Plerixafor Impurity 62
Plerixafor Impurity 62
CAS No.127168-82-5
Chemical FormulaC8H7Br3
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 63 structure
63
普乐沙福杂质63Plerixafor Impurity 63
Plerixafor Impurity 63
CAS No.7398-44-9
Chemical FormulaC8H7Cl3
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 64 structure
64
普乐沙福杂质64Plerixafor Impurity 64
Plerixafor Impurity 64
CAS No.10221-08-6
Chemical FormulaC8H7Cl3
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 66 structure
66
普乐沙福杂质66Plerixafor Impurity 66
Plerixafor Impurity 66
CAS No.199275-80-4
Chemical FormulaC11H24N4
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 67 structure
67
普乐沙福杂质67Plerixafor Impurity 67
Plerixafor Impurity 67
CAS No.295-37-4
Chemical FormulaC10H24N4
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 70 structure
70
普乐沙福杂质70Plerixafor Impurity 70
Plerixafor Impurity 70
CAS No.106-39-8
Chemical FormulaC6H4BrCl
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 71 structure
71
普乐沙福杂质71Plerixafor Impurity 71
Plerixafor Impurity 71
CAS No.74676-47-4
Chemical FormulaC36H46N4O8S4
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 75 structure
75
普乐沙福杂质75Plerixafor Impurity 75
Plerixafor Impurity 75
CAS No.5834-63-9
Chemical FormulaC24H44N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 81 structure
81
普乐沙福杂质81Plerixafor Impurity 81
Plerixafor Impurity 81
CAS No.110078-47-2
Chemical FormulaC70H90N8O12S6
Purity>95%询价On request
10mg25mg50mg100mg
Plerixafor Impurity 84 structure
84
普乐沙福杂质84Plerixafor Impurity 84
Plerixafor Impurity 84
CAS No.295-17-0
Chemical FormulaC14H28
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

普乐沙福 —— 研究文献与合成路线Plerixafor — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 普乐沙福 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Plerixafor. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Robust and Rugged Stability-Indicating HPLC Method for the Determination of Plerixafor and Its Related Impurities in Drug Substances
    Bapatu HR, Maram RK, Murthy RS · Journal of chromatographic science · 2015 · 被引 8cited 8
  2. CXCR4 antagonist AMD3100 (plerixafor): From an impurity to a therapeutic agent
    Wang J, Tannous BA, Poznansky MC, et al. · Pharmacological research · 2020 · 被引 108cited 108

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

普乐沙福 杂质谱研究要点Plerixafor — impurity profiling notes

下面这些是拿到 普乐沙福 的 47 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 47 impurity entries for Plerixafor, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances